Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2941 AL 2955

Parkinson's disease and gut microbiota metabolites: The dual impact of vitamins and functional amyloids

Mirab F, Pirhaghi M, Otzen DE, Saboury AA.

Biochim Biophys Acta Mol Basis Dis. 2025 Aug;1871(6):167862. doi: 10.1016/j.bbadis.2025.167862. Epub 2025 Apr 18.

Comparative analysis of white matter signal alterations in dementia with Lewy bodies and Alzheimer's disease: a systematic review and meta-analysis

Abdi A, Alipour M, Ghanikolahloo M, Magsudy A, HojjatiPour F, Gholamrezanezhad A, Ilaghi M, Anjomrooz M, Sayehmiri F, Hajibeygi R, Fathi M, Assadsangabi R.

Front Radiol. 2025 Apr 4;5:1554345. doi: 10.3389/fradi.2025.1554345. eCollection 2025.

A Case of Parkinsonism Manifested by Exacerbation of Generalized Pustular Psoriasis

Toyoshima R, Shibata S, Kakumoto T, Sato S.

J Dermatol. 2025 Jul;52(7):e614-e615. doi: 10.1111/1346-8138.17750. Epub 2025 Apr 21.

Correction: Gastric emptying time and its correlation with cardiac MIBG in body-first and brain-first subtype Parkinson's disease

Kim MS, Park DG, Shin IJ, An YS, Yoon JH.

J Neurol. 2025 Apr 21;272(5):352. doi: 10.1007/s00415-025-12953-0.

Keeping an eye on Parkinson's disease: color vision and outer retinal thickness as simple and non-invasive biomarkers

Lin J, Finkelstein DI, Anderson AJ, Lee PY, Bui BV, Wijeratne T, Alty JE, Nguyen CTO.

J Neurol. 2025 Apr 21;272(5):351. doi: 10.1007/s00415-025-13080-6.

Correction: Plasma alpha-synuclein predicts cognitive impairment in Parkinson's disease: a systematic review and meta-analysis

Zhu Z, Cordato D, Chen R, Xu YH, Shulruf B, Chan DKY.

J Neurol. 2025 Apr 21;272(5):353. doi: 10.1007/s00415-025-13021-3.

Catecholamine Dysregulation in Former American Football Players: Findings From the DIAGNOSE CTE Research Project

van Amerongen S, Peskind ER, Tripodis Y, Adler CH, Balcer LJ, Bernick C, Alosco ML, Katz D, Banks SJ, Barr WB, Cantu RC, Dodick DW, Geda YE, Mez J, Wethe JV, Weller JL, Daneshvar DH, Palmisano J, Fagle T, Holleck M, Kossow B, Pulukuri S, Tuz-Zahra F, Colasurdo E, Sikkema C, Iliff J, Li G, Shenton ME, Reiman EM, Cummings JL, Stern RA; DIAGNOSE CTE Research Project.

Neurology. 2025 May 27;104(10):e213584. doi: 10.1212/WNL.0000000000213584. Epub 2025 Apr 21.

Sarcopenia in Parkinson's disease: from pathogenesis to interventions

Gui M, Lv L, Hu S, Qin L, Wang C.

Metabolism. 2025 Aug;169:156272. doi: 10.1016/j.metabol.2025.156272. Epub 2025 Apr 19.

Association of GCH1 polymorphism with Parkinson disease susceptibility: A meta-analysis

Wang J, Shao F, Lin H, Zhan S, Wang J.

Medicine (Baltimore). 2025 Apr 18;104(16):e42141. doi: 10.1097/MD.0000000000042141.

The effectiveness and safety of acupuncture for the treatment of cognitive impairment from Parkinson disease: A meta-analysis and systematic review

Hanyu P, Wang A.

Medicine (Baltimore). 2025 Apr 18;104(16):e42148. doi: 10.1097/MD.0000000000042148.

Comparison of phage and plasmid populations in the gut microbiota between Parkinson's disease patients and controls

Duru IC, Lecomte A, Laine P, Shishido TK, Suppula J, Paulin L, Scheperjans F, Pereira PAB, Auvinen P.

Sci Rep. 2025 Apr 21;15(1):13723. doi: 10.1038/s41598-025-96924-5.

Exploring the therapeutic potential of NLRP3 inhibitors in Parkinson's Disease: a systematic review of in-vivo studies

Sadier NS, Hazimeh IA, Khazaal W, Al Sabouri AAK, Almutary AG, Alnuqaydan AM, Abou-Abbas L.

Inflammopharmacology. 2025 May;33(5):2657-2677. doi: 10.1007/s10787-025-01733-x. Epub 2025 Apr 21.

Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer's Disease and Parkinson's Disease

Jung YH, Jo HY, Kim DH, Oh YJ, Kim M, Na S, Song HY, Lee HJ.

Int J Nanomedicine. 2025 Apr 17;20:4903-4917. doi: 10.2147/IJN.S513816. eCollection 2025.

Carbon microelectrodes for the measurement of neurotransmitters with fast-scan cyclic voltammetry: methodology and applications

Alyamni N, Abot JL, Zestos AG.

Front Bioeng Biotechnol. 2025 Apr 7;13:1569508. doi: 10.3389/fbioe.2025.1569508. eCollection 2025.

New horizons for Parkinson's disease treatment?

The Lancet Regional Health-Americas.

Lancet Reg Health Am. 2025 Apr 14;44:101103. doi: 10.1016/j.lana.2025.101103. eCollection 2025 Apr.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias